(Q86885003)
Statements
Darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in diabetic macular edema: a 3-month placebo-controlled study (English)
John Wurzelmann
Li Ye
Mindy H Magee
Ronald P Danis
Peter Adamson
Megan M McLaughlin
Darapladib DME Study Group